⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11458460 | 0.65 | — | — | |
| SCHEMBL968685 | 0.65 | — | — | |
| SCHEMBL486449 | 0.65 | — | — | |
| Methoxymethane SCHEMBL10627012 | 0.64 | CHRM2 (0.31) | — | |
| SCHEMBL7793900 | 0.64 | — | — | |
| SCHEMBL967838 | 0.62 | — | — | |
| SCHEMBL2161284 | 0.61 | — | — | |
| SCHEMBL10306553 | 0.61 | — | — | |
| SCHEMBL113934 | 0.61 | — | — | |
| SCHEMBL208885 | 0.61 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 182 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230137092-A1 | Composition and Method for the Treatment and Prevention of Cardiac, Pulmonary, Dermal, and Renal Fibrosis | EMERALD HEALTH PHARMACEUTICALS INC. (US) | 2023-05-04 | — | — | US | disclosed |
| EP-4099993-A1 | COMPOSITION AND METHOD FOR THE TREATMENT AND PREVENTION OF CARDIAC, PULMONARY, DERMAL, AND RENAL FIBROSIS | Emerald Health Pharmaceuticals Inc. (US) | 2022-12-14 | — | — | EP | disclosed |
| US-20220184003-A1 | Formulations of Cannabidiol Derivatives and Their Use as Modulators of Cannabinoid Receptor Type 2 (CB2) | EMERALD HEALTH PHARMACEUTICALS INC (US) | 2022-06-16 | — | — | US | disclosed |
| US-11268952-B2 | Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof | FIRMENICH INCORPORATED (US) | 2022-03-08 | — | — | US | disclosed |
| CN-113544117-A | Formulations of cannabidiol derivatives and their use as cannabinoid type 2 receptors (CB)２) Use of the modulators of | 埃默拉尔德健康制药公司 | 2021-10-22 | — | — | CN | disclosed |
| WO-2021159059-A1 | COMPOSITION AND METHOD FOR THE TREATMENT AND PREVENTION OF CARDIAC, PULMONARY, DERMAL, AND RENAL FIBROSIS | EMERALD HEALTH PHARMACEUTICALS INC. (US) | 2021-08-12 | — | — | WO | disclosed |
| CN-109195979-B | Catalyst for the hydroformylation of olefins and use thereof | 柏林工业大学 | 2021-06-15 | — | — | CN | disclosed |
| US-10947335-B2 | Triazine-precondensate-aldehyde condensation products and method for obtaining the same | BOREALIS AGROLINZ MELAMINE GMBH (AT) | 2021-03-16 | — | — | US | disclosed |
| US-10941123-B2 | Triazine precondensate and method for obtaining the same | BOREALIS AGROLINZ MELAMINE GMBH (DE) | 2021-03-09 | — | — | US | disclosed |
| EP-3478668-B1 | NOVEL TRIAZINE PRECONDENSATE AND METHOD FOR OBTAINING THE SAME | BOREALIS AGROLINZ MELAMINE (AT) | 2021-02-24 | — | — | EP | disclosed |
| EP-0923734-A1 | QUINOLINE DERIVATIVES AND QUINOLINE COMBINATORIAL LIBRARIES | Trega Biosciences, Inc. (US) | 1999-06-23 | — | — | EP | disclosed |
| US-5874443-A | BIOSYNTHESIS | TREGA BIOSCIENCES, INC. (US) | 1999-02-23 | — | — | US | disclosed |
| US-5840500-A | OPIOD RECEPTORS AS ANALGESICS AND CENTRALLY ACTING PAIN KILLERS | TREGA BIOSCIENCES, INC. (US) | 1998-11-24 | — | — | US | disclosed |
| EP-0863877-A1 | ISOQUINOLINE DERIVATIVES AND ISOQUINOLINE COMBINATORIAL LIBRARIES | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES (US) | 1998-09-16 | — | — | EP | disclosed |
| WO-1998034115-A1 | 4-SUBSTITUTED-QUINOLINE DERIVATIVES AND 4-SUBSTITUTE-QUINOLINE COMBINATORIAL LIBRARIES | TREGA BIOSCIENCES, INC. (US) | 1998-08-06 | — | — | WO | disclosed |
| WO-1998034111-A1 | TRICYCLIC TETRAHYDROQUINOLINE DERIVATIVES AND TRICYCLIC TETRAHYDROQUINOLINE COMBINATORIAL LIBRARIES | TREGA BIOSCIENCES, INC. (US) | 1998-08-06 | — | — | WO | disclosed |
| WO-1998002741-A9 | QUINOLINE DERIVATIVES AND QUINOLINE COMBINATORIAL LIBRARIES | — | 1998-05-22 | — | — | WO | disclosed |
| WO-1998002741-A1 | QUINOLINE DERIVATIVES AND QUINOLINE COMBINATORIAL LIBRARIES | TREGA BIOSCIENCES, INC. (US) | 1998-01-22 | — | — | WO | disclosed |
| WO-1997016428-A1 | ISOQUINOLINE DERIVATIVES AND ISOQUINOLINE COMBINATORIAL LIBRARIES | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES (US) | 1997-05-09 | — | — | WO | disclosed |
| US-4233216-A | INTERMEDIATES FOR OXADETHIACEPHALOSPORINS | SHIONOGI & CO., LTD. (JP) | 1980-11-11 | — | — | US | disclosed |